An in vitro investigation of coagulation effects of exogenous sugammadex using thromboelastography in orthopaedic surgical patients .

An in vitro investigation of coagulation effects of exogenous sugammadex using thromboelastography in orthopaedic surgical patients . - An in vitro investigation of coagulation effects of sugammadex using thromboelastography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029081

Enrollment

Registered

2017-09-11

Start date

2017-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation effects of sugammadex

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologist Physical Class 1-2 Orthopaedic surgery patient

Exclusion criteria

Exclusion criteria: Patients taking aspirin or oral anticoagulant within 14 days Platelet<100,000, PT INR>1.5, or aPTT>50 sec Pregnant woman Liver disease or renal disease Surgical history within 30 days

Design outcomes

Primary

Measure	Time frame
Thromboelastography parameters for citrated whole blood and citrated whole blood with exogenous sugammadex	—

Secondary

Measure	Time frame
Association between percent change of thromboelastography parameters and sugammadex concentration	—

Countries

Asia(except Japan)

Contacts

Public ContactMido Lee

Korea University Guro Hospital Anesthesiology and Pain Medicine

midoyee@gmail.com82226261437

Outcome results